Breakthrough Candidemia in Pediatric Patients With Cancer From a Brazilian Center

Pediatr Infect Dis J. 2021 Mar 1;40(3):251-254. doi: 10.1097/INF.0000000000003027.

Abstract

We analyzed 19 cases of breakthrough candidemia from a referral pediatric cancer center in Brazil. All patients had neutropenia and were under antifungal prophylactic regimens, mostly micafungin (68%). Most of the patients were treated with amphotericin B formulations and 30-day mortality was 21%. Candida parapsilosis was the main etiologic agent (63%), and horizontal transmission was not evidenced by microsatellite analysis.

MeSH terms

  • Antifungal Agents / therapeutic use*
  • Brazil
  • Candida / classification
  • Candidemia / complications*
  • Catheter-Related Infections / drug therapy
  • Catheter-Related Infections / microbiology
  • Child
  • Humans
  • Neoplasms / complications*
  • Retrospective Studies

Substances

  • Antifungal Agents